Concussion Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2020 - 2027

The global concussion market size is expected to reach over USD 8.7 billion by 2027, expanding at a CAGR of 3.4% from forecast period 2020 to 2027.

The global concussion market size was valued at USD 6.5 billion in 2019, according to Vision Research Reports.

Increasing number of injuries being caused to the brain resulting in a high prevalence of associated disorders such as concussion is driving the market in a positive manner.

The rising number of road accidents and sports injuries, coupled with the growing vulnerable aging population, are major factors driving the market. In addition, increasing research activities on concussion diagnosis and treatment as well as the adoption of technologically advanced products are few other factors contributing to market growth.

Report Insights

  • The treatment segment dominated the largest revenue share of 51.1% in 2019. The segment is expected to witness the highest CAGR of 3.6% from 2020 to 2027.
  • The diagnosis segment is further sub-segmented into Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, and X-ray. Due to the higher sensitivity of these devices, they are widely used to assess patients with concussions.
  • North America region accounted for the largest revenue share of 62% in 2019. This is owing to the greater incidence of concussions due to road accidents and sports injuries in the continent, increasing government initiatives, and awareness campaigns regarding concussion prevention, diagnosis, and treatment.
  • In Asia Pacific, the market is expected to witness the highest CAGR of 5% from 2020 to 2027 owing to factors such as growth in the aging population who are more vulnerable to falls, increasing incidence of road accidents, and violence.

Some of the prominent players in the concussion market include:

  • Nihon Kohden Corporation

  • Compumedics Ltd.

  • Integra Lifesciences

  • BioDirection, Inc.

  • InfraScan, Inc.

  • Oculogica

  • Raumedic AG

Market Segmentation

Assessment and Treatment Outlook

    • Diagnosis

      • Magnetic Resonance Imaging (MRI) Devices

      • Computed Tomography (CT) Scan

      • X-ray

      • Others

    • Treatment

Regional Outlook

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Colombia

    • Middle East and Africa (MEA)

      • South Africa

      • Saudi Arabia

      • UAE

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Concussion Market, By Assessment and Treatment

7.1.  Concussion Market, By Assessment and Treatment Type, 2020-2027

7.1.1.    Diagnosis

7.1.1.1.        Market Revenue and Forecast (2016-2027)

7.1.2.    Treatment

7.1.2.1.        Market Revenue and Forecast (2016-2027)

Chapter 8.  Global Concussion Market, Regional Estimates and Trend Forecast

8.1.  North America

8.1.1.    Market Revenue and Forecast, By Assessment and Treatment (2016-2027)

8.1.2.    U.S.

8.1.3.    Rest of North America

8.1.3.1.        Market Revenue and Forecast, By Assessment and Treatment (2016-2027)

8.2.  Europe

8.2.1.    Market Revenue and Forecast, By Assessment and Treatment (2016-2027)

8.2.2.    UK

8.2.2.1.        Market Revenue and Forecast, By Assessment and Treatment (2016-2027)

8.2.3.    France

8.2.3.1.        Market Revenue and Forecast, By Assessment and Treatment (2016-2027)

8.2.4.    Rest of Europe

8.2.4.1.        Market Revenue and Forecast, By Assessment and Treatment (2016-2027)

8.3.  APAC

8.3.1.    Market Revenue and Forecast, By Assessment and Treatment (2016-2027)

8.3.2.    India

8.3.2.1.        Market Revenue and Forecast, By Assessment and Treatment (2016-2027)

8.3.3.    China

8.3.3.1.        Market Revenue and Forecast, By Assessment and Treatment (2016-2027)

8.3.4.    Japan

8.3.4.1.        Market Revenue and Forecast, By Assessment and Treatment (2016-2027)

8.3.5.    Rest of APAC

8.3.5.1.        Market Revenue and Forecast, By Assessment and Treatment (2016-2027)

8.4.  MEA

8.4.1.    Market Revenue and Forecast, By Assessment and Treatment (2016-2027)

8.4.2.    GCC

8.4.2.1.        Market Revenue and Forecast, By Assessment and Treatment (2016-2027)

8.4.3.    North Africa

8.4.3.1.        Market Revenue and Forecast, By Assessment and Treatment (2016-2027)

8.4.4.    South Africa

8.4.4.1.        Market Revenue and Forecast, By Assessment and Treatment (2016-2027)

8.4.5.    Rest of MEA

8.4.5.1.        Market Revenue and Forecast, By Assessment and Treatment (2016-2027)

8.5.  Latin America

8.5.1.    Market Revenue and Forecast, By Assessment and Treatment (2016-2027)

8.5.2.    Brazil

8.5.2.1.        Market Revenue and Forecast, By Assessment and Treatment (2016-2027)

8.5.3.    Rest of LATAM

8.5.3.1.        Market Revenue and Forecast, By Assessment and Treatment (2016-2027)

Chapter 9.    Company Profiles

9.1.  Nihon Kohden Corporation

9.1.1.    Company Overview

9.1.2.    Product Offerings

9.1.3.    Financial Performance

9.1.4.    Recent Initiatives

9.2.  Compumedics Ltd.

9.2.1.    Company Overview

9.2.2.    Product Offerings

9.2.3.    Financial Performance

9.2.4.    Recent Initiatives

9.3.  Integra Lifesciences

9.3.1.    Company Overview

9.3.2.    Product Offerings

9.3.3.    Financial Performance

9.3.4.    Recent Initiatives

9.4.  BioDirection, Inc.

9.4.1.    Company Overview

9.4.2.    Product Offerings

9.4.3.    Financial Performance

9.4.4.    Recent Initiatives

9.5.  InfraScan, Inc.

9.5.1.    Company Overview

9.5.2.    Product Offerings

9.5.3.    Financial Performance

9.5.4.    Recent Initiatives

9.6.  Oculogica

9.6.1.    Company Overview

9.6.2.    Product Offerings

9.6.3.    Financial Performance

9.6.4.    Recent Initiatives

9.7.  Raumedic AG.

9.7.1.    Company Overview

9.7.2.    Product Offerings

9.7.3.    Financial Performance

9.7.4.    Recent Initiatives

Chapter 10.  Research Methodology

10.1.              Primary Research

10.2.              Secondary Research

10.3.              Assumptions

Chapter 11.  Appendix

11.1.              About Us

Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers